Table 3. Clinical follow up from 2 years post-HSCT until present.
| Code a | Iv Ig a | Common warts | Severe HPV disease b | E.N.T infections | Diarrhea | Respiratory infection or disease | Other | |
|---|---|---|---|---|---|---|---|---|
| Children with JAK3 or IL2RG defect | ||||||||
| P1 |  |
1 | 0 | 0 | 1 | 1 c | 0 | 0 |
| P2 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| P3 |  |
1 | 1 | 0 | 0 | 0 | 0 | pancreatic insufficiency |
| P4 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| P5 |  |
1 | 0 | 0 | 0 | 1 | 0 | hepatic granulomatous disease, IBD-like disease, onychomycosis |
| P6 |  |
0 | 1 | 1 | 0 | 0 | 0 | 0 |
| P7 |  |
0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Adults with JAK3 or IL2RG defect | ||||||||
| P8 |  |
1 | 0 | 0 | 0 | 0 | 0 | 0 |
| P9 |  |
0 | 1 | 1 | 0 | 0 | 0 | 0 |
| P10 |  |
0 | 0 | 0 | 1 | 0 | 0 | 0 |
| P11 |  |
0 | 1 | 0 | 0 | 0 | 0 | epilepsy |
| P12 |  |
1 | 0 | 0 | 0 | 0 | 1 | 0 |
| P13 |  |
1 | 0 | 0 | 0 | 0 | 0 | pheochromocytoma |
| P14 |  |
0 | 1 | 0 | 0 | 0 | 0 | 0 |
| P15 |  |
1 | 0 | 0 | 0 | 0 | 0 | 0 |
| P16 |  |
1 | 0 | 0 | 0 | 0 | 0 | 0 |
| P17 |  |
0 | 1 | 0 | 0 | 0 | 0 | 0 |
| P18 |  |
1 | 1 | 0 | 1 | 0 | 1 | 0 |
| CDC patients | ||||||||
| C1 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| C2 |  |
1 d | 0 | 0 | 0 | 0 | 0 | 0 |
| C3 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| C4 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| C5 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| C6 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| C7 |  |
0 | 0 | 0 | 0 | 0 | 0 | mediastinal lymphoma post HSCT |
| C8 |  |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
a
immunoglobulin replacement
b
more than 30 cutaneous lesions during at least 2 years
c
inflammatory bowel-like disease improved after unconditioned T depleted boost performed 2 years after HSCT
d
absence of B cell reconstitution after anti CD20 monoclonal antibodies given for autoimmune hemolytic anemia
P19, P20 and P21 are not indicated because peripheral blood ILC evaluation have been only performed before transplantation
ND: not done